Leidos Holdings, Inc. (LDOS) $108.21
Leidos is trading at a staggering 47% discount from its 52-week high, leaving investors to wonder if this is a value trap or the ultimate entry window before August earnings.
52-wk High $205.77
📌 Investment Snapshot
- Trading at $108.21 with a compressed 9.9x P/E ratio versus historical norms.
- Latest Q1 Revenue of $4.40B and EPS of $2.60 show stable operational footing.
- Massive 42% upside to mean analyst target of $153.67 suggests significant mispricing.
- Technical Confluence Score of 80/100 reveals strong structural support near $104.
⏳ WAIT
Leidos is currently trapped in a heavy markdown phase despite robust earnings and a high technical confluence score. The stock sits just 8% above its 52-week low, signaling a potential bottoming process that requires confirmation.
| 📍 Entry Zone | $104.50 or below | 🛑 Stop-Loss | $97.50 |
| 📋 Adjust If | Earnings on Aug 4th miss revenue estimates by more than 3%. | ||
The Investment Case — Why Now?
The narrative surrounding Leidos has shifted from growth darling to a value play over the last 90 days as the stock shed 30% of its value. While the broader market climbed, LDOS faced selling pressure that decoupled its price from a healthy $10.93 EPS. This divergence often creates a coiled spring effect, but the lack of immediate catalysts suggests the market is waiting for the August 4th earnings report to re-rate the sector.
The primary risk remains the 4.55% 10Y Treasury yield, which continues to pressure high-duration government service contracts. If the federal budget faces further sequestration fears, Leidos’s $13.6B market cap could see another 10% haircut toward the $98 support level. Can you justify holding a defense contractor when the technical trend is still firmly bearish despite the low P/E?
🤔 Can you justify holding a defense contractor when the technical trend is still firmly bearish despite the low P/E?
🏢 Company Overview
| Detail | Value |
|---|---|
| Sector | Technology |
| Industry | IT Services |
| Dividend Yield | 1.59% |
| Employees | 47,000 (est) |
Open chart on TradingView →
📈 Price Action & Technicals
Golden Cross
Inside VA
Buy-side Sweep at $104.29 on 2026-07-14
The price remains pinned below the SMA50 ($118.34) and SMA200 ($163.77), confirming a dominant bearish trend that has yet to break. Resistance at the SMA50 must be reclaimed to signal any structural shift.
RSI at 59.5 is surprisingly high given the recent price collapse, suggesting a lack of true capitulation. The MACD is attempting a bullish crossover, but it remains deep in negative territory, which often leads to ‘fake-out’ rallies.
Anchored VWAP at $104.98 serves as the current floor, with the stock recently bouncing off this level. This aligns with the Value Area Low ($103.07), marking a critical zone where institutional buyers have historically stepped in.
Three recent liquidity sweeps, including the July 14th buy-side sweep at $104.29, indicate that smart money is hunting for entries. However, the volume ratio of 0.61x shows a lack of conviction behind the current price stabilization.
Historically, when LDOS trades this far below its SMA200, it requires a high-volume reversal candle to mark a bottom. We are currently seeing a ‘drift’ rather than a ‘drive,’ which keeps the risk of a final leg down to $98 on the table.
⚖ Peer P/E Comparison
| Ticker | Company | P/E (TTM) |
|---|---|---|
| LDOS | Leidos Holdings | 9.9x |
| CACI | CACI International | 18.4x |
| SAIC | Science Applications | 14.2x |
| BAH | Booz Allen Hamilton | 24.1x |
| SPY | S&P 500 Avg | 21.5x |
💰 Earnings Deep Dive
| Period | Revenue | EPS | YoY |
|---|---|---|---|
| Q1 2026 | $4.40B | $2.60 | +3.5% |
| Q4 2025 | $4.21B | $2.57 | +2.1% |
| Q3 2025 | $4.47B | $2.87 | +5.2% |
| Q2 2025 | $4.25B | $3.03 | +4.8% |
Leidos generated $0.3B in Free Cash Flow last quarter, supporting $0.2B in share buybacks. This aggressive capital return program at these depressed price levels should eventually provide a floor for the stock.
Revenue has remained remarkably stable between $4.2B and $4.5B over the last year, yet the stock price has decoupled. The market is clearly pricing in a future margin squeeze that has not yet appeared in the EPS data. With earnings due August 4th, the focus will be on whether the $10.93 trailing EPS is sustainable in a higher-for-longer interest rate environment.
🚀 Growth Drivers — What Moves the Stock
- Defense Modernization 🟢 Upside Surprise — Increased spending on cybersecurity and digital transformation within the DoD favors Leidos’s core competencies.
- Health IT Expansion 🟡 Priced In — Continued rollout of modernized electronic health records for federal agencies provides long-term recurring revenue.
- Capital Deployment 🟢 Upside Surprise — Management’s commitment to buybacks at sub-10x P/E could significantly boost EPS in 2027.
🤔 Would you trust management’s buyback strategy if revenue growth slows to low single digits?
🏦 Smart Money & Institutional Positioning
13F Holdings
| Institution | Shares (K) |
|---|---|
| Blackrock Inc. | 9,496 |
| Vanguard Capital Management | 8,260 |
| State Street Corporation | 6,116 |
Holdings reflect most recent 13F (45-day lag).
Insider Transactions
| Name | Title | Date | Type | Shares |
|---|---|---|---|---|
| KRAEMER HARRY M. | Director | 2026-07-06 | Purchase | 310 |
| CAGE CHRISTOPHER R. | CFO | 2026-06-30 | Purchase | 113 |
Short Interest
| Short % Float | Days to Cover |
|---|---|
| 5.3% | 3.0 |
⚠ Key Risk Factors
~$0.5B valuation impact
~$1.2B backlog risk
🎯 Guidance & Wall Street View
Management has maintained a steady outlook, focusing on operational efficiency and high-value contract wins. Analysts remain bullish on the long-term value despite the recent price action.
| High Target | Mean Target | Low Target | Analysts | Consensus |
|---|---|---|---|---|
| $225.00 | $153.67 | $110.00 | 15 | Buy |
| Firm | Rating | Target | Date | Action |
|---|---|---|---|---|
| Goldman Sachs | Neutral | $145.00 | 2026-07-14 | Maintained |
| JP Morgan | Overweight | $160.00 | 2026-07-13 | Maintained |
| B of A Securities | Neutral | $130.00 | 2026-06-17 | Downgrade |
While the consensus rating is ‘Buy,’ recent downgrades from B of A and Jefferies suggest a cooling of sentiment. The mean target of $153.67 implies the stock is significantly undervalued if it can return to its historical P/E multiple.
Open chart on TradingView →
📊 Bull vs Bear — Probability-Weighted Scenarios
🐂 Bull Case
- P/E expansion back to 15x industry average.
- Major defense contract win exceeding $5B.
📊 Base Case
Leidos stabilizes near $110 as earnings confirm steady margins and buybacks continue.
🐻 Bear Case
- Revenue contraction due to federal budget cuts.
- Break below $98 support leading to technical capitulation.
🎯 Investor Action Plan — By Profile
Stay on the sidelines until LDOS reclaims the $113.50 level on 1.5x average volume. This would fill the bearish FVG and signal that the current bottoming process has institutional backing.
The 9.9x P/E is attractive, but the RSI at 59.5 suggests we haven’t seen the ‘blood in the streets’ moment yet. Wait for a test of the $101-$104 zone or post-earnings clarity before building a full position.
If you already own LDOS, the dividend and buybacks make this a hold. The fundamental thesis of government IT reliance remains intact, even if the stock price is currently broken.
If you’re interested in the Technology sector, also read:
❓ Investor FAQ — People Also Ask
Q: Why is Leidos stock dropping despite good earnings?
The decline is primarily driven by sector-wide multiple compression and macro concerns over government spending, rather than company-specific failures.
Q: Is the 1.59% dividend safe?
Yes, with a low P/E and $0.3B in quarterly free cash flow, the dividend is well-covered and likely to grow.
Q: What is the key technical level to watch?
The $104.98 anchored VWAP is the line in the sand; a daily close below this could trigger a slide to the $98 52-week low.
📖 New to these terms? P/E Ratio · Free Cash Flow · Insider Signals · Stop-Loss · RSI
📊 Want to verify if this analysis still holds?
📋 Disclaimer
This analysis is for informational purposes only and does not constitute financial advice. The author has no position in LDOS at the time of writing.
All active positions and their real-time performance are tracked on our Investment Log.
#LDOS #Leidos #DefenseStocks #ValueInvesting #StockMarket2026 #TechnicalAnalysis #NYSE